文献速递外周动脉疾病主动脉疾病

激光在非冠状动脉动脉疾病中的应用

Laser Uses in Noncoronary Arterial Disease.
PubMed 文献 · Ann Vasc Surg · 2018-08-15

本综述依据PRISMA指南检索英文文献,最终纳入26篇文献分析激光在非冠状动脉动脉疾病中的应用。准分子激光血管成形术(ELA)用于外周动脉疾病(PAD)时,随访15±7个月一期通畅率65%±20%;用于支架内再狭窄时技术成功率98%,随访10±4个月一期通畅率68%±18%。激光斑块旋切及激光辅助技术是血管外科医师和介入医师的重要工具。

要点

  • ELA用于PAD动脉粥样硬化斑块时,平均随访15±7个月一期通畅率65%±20%,术中远端栓塞率平均5%。
  • ELA用于支架内再狭窄时平均技术成功率98%,术中远端栓塞率9%,随访10±4个月一期通畅率68%±18%。
  • 8篇文献描述ELA在血管内治疗中的超说明书适应证,其中5篇涉及复杂主动脉瘤的原位开窗。

核心结论

  • 激光斑块旋切和激光辅助技术是血管外科医师和介入医师装备库中的重要组成部分。

研究设计与样本

  • 本综述按照系统综述和Meta分析优先报告条目(PRISMA)指南检索英文文献,共筛选出106篇相关论文。
  • 排除不相关论文67篇、通讯和评论6篇、综述文章7篇后,最终纳入26篇文章作为本综述的基础。

主要发现

  • 共有18篇文章纳入ELA在PAD中应用的分析,其中9篇与动脉粥样硬化斑块相关。
  • 动脉粥样硬化斑块相关分析的平均随访为15±7个月,一期通畅率为65%±20%,术中远端栓塞率平均为5%。
  • 另有8篇文章关注支架内再狭窄,平均技术成功率为98%,术中远端栓塞率为9%。
  • 支架内再狭窄分析的平均随访为10±4个月,一期通畅率为68%±18%。
  • 8篇文章描述了ELA在血管内治疗中的超说明书适应证,包括5篇关于复杂主动脉瘤原位开窗的论文。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the past decade, excimer laser angioplasty (ELA) has emerged in the field of peripheral artery disease (PAD). Laser indications now extend to off-label uses, such as in situ fenestration of aortic endograft. The aim of this study was to review the different therapeutics applications of lasers in arterial disease treatment. METHODS: We reviewed the English-language literature using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. We selected 106 relevant papers. We excluded unrelated papers (n = 67), letters and commentaries (n = 6), and review articles (n = 7), leaving 26 articles to form the basis of this review. RESULTS: A total of 18 articles were included in the analysis of ELA applications in PAD. Nine articles were related to atherosclerotic plaques. With a mean follow-up of 15 ± 7 months, primary patency was 65% ± 20%. The mean distal embolism rate during the procedure was 5%. Eight more articles focused on in-stent restenosis. The mean technical success was 98%, and the rate of distal embolism during the procedure was 9%. With a mean follow-up of 10 ± 4 months, primary patency was 68% ± 18%. Eight articles described "off-label" excimer laser indications in endovascular therapy, including 5 papers regarding in situ fenestrations for complex aortic aneurysms. CONCLUSION: Laser atherectomy and laser-assisted techniques are an important part of a vascular surgeon and interventionalist's armamentarium.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Jayet J, Coscas R, Heim F, et al. Laser Uses in Noncoronary Arterial Disease. Ann Vasc Surg. 2018. PMID: 30118856. doi:10.1016/j.avsg.2018.06.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。